Literature DB >> 2984102

Storage of alpha-1-antitrypsin in intrahepatic bile duct cells in alpha-1-antitrypsin deficiency (Pi Z phenotype).

F Callea, J Fevery, G Massi, J de Groote, V J Desmet.   

Abstract

Storage of alpha-1-antitrypsin (AAT) has been found in a small number of bile duct cells in liver tissue specimens from patients with Pi MZ, Pi SZ and Pi ZZ phenotypes. The storage appeared in the form of intracellular AAT immunoreactive inclusions. On EM investigation, AAT-like material was detected within cisternae of the RER and SER. Such AAT inclusions were found in proliferating bile ductules in conditions such as cirrhosis, focal nodular hyperplasia and extrahepatic obstruction. They were also observed in normal biliary structures at the level of the canals of Hering, bile ductules and interlobular ducts in 13 out of 47 cases. These findings are interpreted as indicating that the intrahepatic bile duct cells are a further source of AAT, and that in case of defective export of AAT from the cell, as is the case for the Z protein, the protein accumulates not only in hepatocytes but in biliary cells as well.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984102     DOI: 10.1111/j.1365-2559.1985.tb02973.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes.

Authors:  A J Demetris; E C Seaberg; A Wennerberg; J Ionellie; G Michalopoulos
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 2.  Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases.

Authors:  Francesco Callea; Paola Francalanci; Isabella Giovannoni
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 3.  Current Treatment Options for Cystic Fibrosis-Related Liver Disease.

Authors:  Katharina Staufer
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.